Flibanserin tablet

Flibanserin tablet

Form: Tablet

Strength: 100 mg

Reference Brands: Addyi(US)

Category: Sexual Wellness

Flibanserin tablets, marketed as Addyi, are approved in the US by the FDA for the treatment of premenopausal women with hypoactive sexual desire disorder (HSDD). Regulatory requirements include a comprehensive dossier with clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, the FDA conducts detailed review processes, while the EU’s EMA assesses compliance with regional safety and quality standards—though approval in Europe remains pending or varies by country. For guidance on dossier preparation, regulatory pathways, and market access strategies, visit PharmaTradz. Ensuring thorough compliance supports timely approval, safe use, and broader global availability, improving quality of life for women worldwide.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Shilajit Capsules/Tablet

Strength: 300 mg–600 mg per dose.

Form: Tablet/ Capsules

Reference Brands: Pure Himalayan Shilajit Resin(US)

View Details Get Enquiry
Tribulus Terrestris Capsules

Strength: 500-750 mg

Form: Capsules

Reference Brands: Optimum Nutrition Tribulus(US)

View Details Get Enquiry
Horny Goat Weed Capsules

Strength: 500–700 mg

Form: Capsules

Reference Brands: NOW Foods Horny Goat Weed(US)

View Details Get Enquiry
Ashwagandha Capsules

Strength: 300-600 mg

Form: Capsules

Reference Brands: NOW Foods Ashwagandha

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.